NASDAQ : EDIT
Editas Medicine, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.67 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 410.06M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Editas Medicine, Inc. (EDIT) reported revenue of 47.01M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 47.01M | 40.52M | 32.31M | 78.12M | 19.71M | 25.54M |
| Cost of Revenue | 84.96M | 89.95M | 199.25M | 177.65M | 174.96M | 142.51M |
| Gross Profit | -37.95M | -49.43M | -166.93M | -99.53M | -155.25M | -116.96M |
| Selling, General & Admin | 45.51M | 49.90M | 71.99M | 69.65M | 70.70M | 76.18M |
| Operating Expenses | 45.51M | 49.90M | 71.99M | 69.65M | 70.70M | 76.18M |
| Operating Income | -83.46M | -99.34M | -238.92M | -169.18M | -225.95M | -193.15M |
| Interest Expense | -4.07M | -6.17M | -2.19M | |||
| Interest & Investment Income | 6.08M | 8.31M | 16.25M | 17.57M | 5.52M | 607.00K |
| Other Non Operating Income (Expenses) | 2.79M | 37.00K | ||||
| EBT Excluding Unusual Items | -78.66M | -97.20M | -224.86M | -151.62M | -220.43M | -192.50M |
| Merger & Restructuring Charges | 7.63M | -56.92M | -12.23M | |||
| Gain (Loss) on Sale of Investments | -2.89M | -2.19M | -3.00K | -1.60M | ||
| Gain (Loss) on Sale of Assets | -34.00K | -3.76M | ||||
| Pretax Income | -73.95M | -160.06M | -237.09M | -153.22M | -220.43M | -192.50M |
| Net Income | -73.95M | -160.06M | -237.09M | -153.22M | -220.43M | -192.50M |
| Net Income to Common | -73.95M | -160.06M | -237.09M | -153.22M | -220.43M | -192.50M |
| Shares Outstanding (Basic) | 101.20M | 88.75M | 82.34M | 75.97M | 68.66M | 67.62M |
| Shares Outstanding (Diluted) | 101.20M | 88.75M | 82.34M | 75.97M | 68.66M | 67.62M |
| EPS (Basic) | -0.73 | -1.80 | -2.88 | -2.02 | -3.21 | -2.85 |
| EPS (Diluted) | -0.73 | -1.80 | -2.88 | -2.02 | -3.21 | -2.85 |
| Free Cash Flow | -120.55M | -165.85M | -219.11M | -136.90M | -181.47M | -171.78M |
| Free Cash Flow Per Share | -1.19 | -1.87 | -2.66 | -1.80 | -2.64 | -2.54 |
| Gross Margin | -80.75% | -122.00% | -127.40% | |||
| Operating Margin | -177.56% | -245.15% | -739.37% | -216.56% | -1,146.26% | -756.13% |
| Profit Margin | -157.32% | -395.01% | -733.72% | -196.12% | -1,118.26% | -753.61% |
| Free Cash Flow Margin | -256.46% | -409.30% | -678.06% | -175.23% | -920.59% | -672.49% |
| EBITDA | -81.03M | -94.06M | -233.11M | -163.12M | -219.61M | -188.09M |
| EBITDA Margin | -172.40% | -232.13% | -208.80% | |||
| D&A For EBITDA | 2.42M | 5.28M | 5.81M | 6.06M | 6.34M | 5.05M |
| EBIT | -83.46M | -99.34M | -238.92M | -169.18M | -225.95M | -193.15M |
| EBIT Margin | -177.56% | -245.15% | -216.56% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 181.81M | 146.65M | 131.54M | 123.65M | 141.52M | 203.52M |
| Short-Term Investments | 29.83M | 138.37M | 199.46M | 202.75M | 296.33M | |
| Cash & Short-Term Investments | 211.65M | 146.65M | 269.91M | 323.11M | 344.27M | 499.85M |
| Accounts Receivable | 2.73M | 15.18M | 16.27M | 10.19M | 5.14M | 267.00K |
| Receivables | 2.73M | 15.18M | 16.27M | 10.19M | 5.14M | 267.00K |
| Prepaid Expenses | 3.70M | 2.07M | 3.14M | 7.53M | 7.33M | 7.20M |
| Total Current Assets | 218.07M | 163.90M | 289.31M | 340.83M | 356.75M | 507.31M |
| Property, Plant & Equipment | 16.32M | 19.66M | 47.05M | 45.71M | 59.22M | 43.29M |
| Long-Term Investments | 104.02M | 93.10M | 120.07M | |||
| Other Long-Term Assets | 2.98M | 2.98M | 5.22M | 8.59M | 5.25M | 6.81M |
| Total Assets | 237.36M | 186.53M | 341.59M | 499.15M | 514.32M | 677.48M |
| Accounts Payable | 4.74M | 2.60M | 5.49M | 8.27M | 9.51M | 5.05M |
| Accrued Expenses | 11.76M | 24.84M | 44.10M | 34.56M | 31.30M | 20.19M |
| Current Portion of Leases | 6.51M | 6.03M | 14.65M | 12.16M | 11.08M | 10.31M |
| Current Unearned Revenue | 39.81M | 5.00M | 11.22M | 8.22M | 8.22M | 11.33M |
| Other Current Liabilities | 5.61M | 7.77M | 1.76M | |||
| Total Current Liabilities | 68.43M | 46.25M | 77.22M | 63.22M | 60.11M | 46.88M |
| Long-Term Leases | 9.00M | 12.07M | 20.38M | 24.37M | 32.86M | 16.07M |
| Long-Term Unearned Revenue | 52.24M | 98.11M | 106.64M | 60.67M | 60.67M | 60.89M |
| Other Long-Term Liabilities | 2.41M | 2.81M | 3.07M | 1.80M | ||
| Total Liabilities | 132.08M | 159.25M | 207.31M | 150.06M | 153.64M | 123.84M |
| Common Stock | 15.00K | 10.00K | 8.00K | 8.00K | 7.00K | 7.00K |
| Additional Paid-In Capital | 1.78B | 1.66B | 1.60B | 1.58B | 1.44B | 1.41B |
| Retained Earnings | -1.67B | -1.63B | -1.47B | -1.23B | -1.08B | -857.70M |
| Comprehensive Income & Other | -6.00K | 268.00K | 198.00K | -3.60M | -493.00K | |
| Total Common Equity | 105.28M | 27.29M | 134.27M | 349.10M | 360.68M | 553.64M |
| Shareholders' Equity | 105.28M | 27.29M | 134.27M | 349.10M | 360.68M | 553.64M |
| Total Liabilities & Equity | 237.36M | 186.53M | 341.59M | 499.15M | 514.32M | 677.48M |
| Total Debt | 15.51M | 18.10M | 35.03M | 36.54M | 43.95M | 26.38M |
| Net Cash (Debt) | 196.13M | 128.54M | 234.88M | 390.60M | 393.43M | 593.54M |
| Net Cash Per Share | 1.94 | 1.45 | 2.85 | 5.14 | 5.73 | 8.78 |
| Filing Date Shares Outstanding | 153.58M | 97.87M | 82.98M | 81.81M | 67.47M | 68.46M |
| Total Common Shares Outstanding | 153.53M | 97.87M | 82.73M | 81.77M | 67.35M | 68.44M |
| Working Capital | 149.63M | 117.65M | 212.09M | 277.61M | 296.64M | 460.43M |
| Book Value Per Share | 0.69 | 0.28 | 1.62 | 4.27 | 5.36 | 8.09 |
| Tangible Book Value | 105.28M | 27.29M | 134.27M | 349.10M | 360.68M | 553.64M |
| Tangible Book Value Per Share | 0.69 | 0.28 | 1.62 | 4.27 | 5.36 | 8.09 |
| Machinery | 20.55M | 23.15M | 30.88M | 26.37M | 25.55M | 22.72M |
| Construction In Progress | 827.00K | 2.06M | 1.57M | 1.53M | ||
| Leasehold Improvements | 8.40M | 8.40M | 11.75M | 9.65M | 9.76M | 8.16M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -73.95M | -160.06M | -237.09M | -153.22M | -220.43M | -192.50M |
| Depreciation & Amortization | 2.42M | 5.28M | 5.81M | 6.06M | 6.34M | 5.05M |
| Loss (Gain) From Sale of Assets | 145.00K | 5.95M | 149.00K | |||
| Loss (Gain) From Sale of Investments | -204.00K | -902.00K | -5.79M | -4.82M | -724.00K | 1.66M |
| Stock-Based Compensation | 8.65M | 10.00M | 21.42M | 19.80M | 29.29M | 43.40M |
| Other Operating Activities | 3.99M | 5.72M | 1.77M | 1.60M | ||
| Change in Accounts Receivable | -2.14M | 1.09M | -6.08M | -5.04M | -4.88M | 5.78M |
| Change in Accounts Payable | -2.45M | -2.89M | -2.29M | -1.49M | 4.37M | -1.14M |
| Change in Unearned Revenue | -17.89M | -15.92M | -8.46M | -3.33M | -22.71M | |
| Change in Other Net Operating Assets | -38.44M | -13.52M | 20.28M | 4.94M | 12.02M | -3.35M |
| Operating Cash Flow | -119.86M | -165.24M | -210.28M | -132.18M | -177.35M | -163.80M |
| Capital Expenditures | -691.00K | -607.00K | -8.83M | -4.72M | -4.12M | -7.98M |
| Sale of Property, Plant & Equipment | 274.00K | 269.00K | 18.00K | |||
| Investment in Securities | 10.31M | 139.01M | 170.97M | 988.00K | 118.17M | -46.49M |
| Investing Cash Flow | 9.89M | 138.67M | 162.15M | -3.73M | 114.07M | -54.47M |
| Issuance of Common Stock | 152.03M | 43.34M | 783.00K | 118.04M | 1.28M | 282.11M |
| Other Financing Activities | -2.87M | 55.24M | ||||
| Financing Cash Flow | 152.03M | 40.47M | 56.03M | 118.04M | 1.28M | 282.11M |
| Net Cash Flow | 42.07M | 13.90M | 7.89M | -17.87M | -62.00M | 63.84M |
| Free Cash Flow | -120.55M | -165.85M | -219.11M | -136.90M | -181.47M | -171.78M |
| Free Cash Flow Margin | -256.46% | -409.30% | -678.06% | -175.23% | -920.59% | -672.49% |
| Free Cash Flow Per Share | -1.19 | -1.87 | -2.66 | -1.80 | -2.64 | -2.54 |
| Levered Free Cash Flow | -44.32M | -71.48M | -122.46M | -87.81M | -102.27M | -85.55M |
| Unlevered Free Cash Flow | -41.77M | -67.62M | -121.09M | -87.81M | -102.27M | -85.55M |
| Cash Interest Paid | 5.00M | 2.13M | ||||
| Change in Working Capital | -60.92M | -31.23M | 3.45M | -1.59M | 8.18M | -21.41M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 406.99M | 200.12M | 104.84M | 827.35M | 596.59M | 1.80B |
| Enterprise Value | 210.85M | 54.12M | -121.76M | 415.55M | 139.43M | 1.17B |
| Last Close Price | 2.67 | 2.05 | 1.27 | 10.13 | 8.87 | 26.55 |
| PS Ratio | 8.72 | 4.94 | 3.24 | 10.59 | 30.27 | 70.31 |
| PB Ratio | 3.89 | 7.33 | 0.78 | 2.37 | 1.65 | 3.24 |
| P/TBV Ratio | 3.89 | 7.33 | 0.78 | 2.37 | 1.65 | 3.24 |
| EV/Sales Ratio | 4.55 | 1.34 | 5.32 | 7.07 | 45.71 | |
| Debt / Equity Ratio | 0.15 | 0.66 | 0.26 | 0.10 | 0.12 | 0.05 |
| Net Debt / Equity Ratio | -1.86 | -4.71 | -1.75 | -1.12 | -1.09 | -1.07 |
| Net Debt / EBITDA Ratio | 2.42 | 1.37 | 1.01 | 2.40 | 1.79 | 3.16 |
| Net Debt / FCF Ratio | 1.63 | 0.78 | 1.07 | 2.85 | 2.17 | 3.46 |
| Asset Turnover | 0.21 | 0.15 | 0.08 | 0.15 | 0.03 | 0.04 |
| Quick Ratio | 3.13 | 3.50 | 3.71 | 5.27 | 5.81 | 10.67 |
| Current Ratio | 3.19 | 3.54 | 3.75 | 5.39 | 5.93 | 10.82 |
| Return on Equity (ROE) | -118.82% | -198.14% | -98.10% | -43.17% | -48.22% | -40.64% |
| Return on Assets (ROA) | -23.29% | -23.51% | -35.52% | -20.87% | -23.70% | -19.31% |
| Return on Capital Employed (ROCE) | -49.40% | -70.80% | -90.40% | -38.80% | -49.70% | -30.60% |
| Earnings Yield | -27.57% | -79.98% | -226.16% | -18.52% | -36.95% | -10.72% |
| FCF Yield | -29.40% | -82.88% | -209.00% | -16.55% | -30.42% | -9.56% |
| Buyback Yield / Dilution | -21.72% | -7.78% | -8.39% | -10.63% | -1.55% | -15.37% |